Fig. 4
CD59 and AAT predict progression of albuminuria in normoalbuminuric patients. Albuminuria was evaluated at sampling and at least 1Â year later and individuals were classified as non-progressors or progressors (a, b, c). Levels of CD59 and AAT in urine when those individuals were normoalbuminuric can already distinguish both groups, anticipating future development or not of albuminuria (d, e)